Berberine and cinnamaldehyde together prevent lung carcinogenesis

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Nutrient restriction is a promising cancer therapy.
• Berberine and cinnamaldehyde activate AMP-activated protein kinase (AMPK).

Purpose of the Study:

• To investigate if berberine and cinnamaldehyde synergistically prevent lung carcinogenesis via tumor cell starvation.
• To explore the underlying molecular mechanisms involving AMPK, mTOR, AQP-1, and NF-κB.

Main Methods:

• Urethane-induced lung carcinogenesis model in mice.
• In vitro studies using A549 lung cancer cells.
• Analysis of AMPK, mTOR, AQP-1, and NF-κB expression.
• Assessment of cell apoptosis, proliferation, autophagy, and wound healing.
• Inhibition studies using rapamycin, HgCl2, and Z-VAD-FMK.

Main Results:

• Combined berberine and cinnamaldehyde reduced lung carcinogenesis in mice and reversed aberrant protein expression.
• In vitro, the combination induced apoptosis, inhibited proliferation, autophagy, and wound healing.
• Upregulation of AMPK and downregulation of AQP-1 were observed.
• Effects were mediated by mTOR and AQP-1, but not caspase pathways.
• Reduced substance permeability and intracellular ATP concentrations were noted.

Conclusions:

• Berberine and cinnamaldehyde combination effectively starves lung tumor cells.
• The mechanism involves AMPK-mediated downregulation of AQP-1, limiting nutrient uptake.
• This strategy shows potential for lung cancer prevention and treatment.